S. Peter Klinken

1.4k total citations
34 papers, 1.0k citations indexed

About

S. Peter Klinken is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, S. Peter Klinken has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Hematology. Recurrent topics in S. Peter Klinken's work include Erythrocyte Function and Pathophysiology (11 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Acute Myeloid Leukemia Research (5 papers). S. Peter Klinken is often cited by papers focused on Erythrocyte Function and Pathophysiology (11 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Acute Myeloid Leukemia Research (5 papers). S. Peter Klinken collaborates with scholars based in Australia, United States and Germany. S. Peter Klinken's co-authors include Peta A. Tilbrook, Janet W. Hartley, Wallace Y. Langdon, S K Ruscetti, Herbert C. Morse, Evan Ingley, Mohinder Sarna, Patricia M. Stevenson, Shane M. Colley and James H. Williams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

S. Peter Klinken

33 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Peter Klinken Australia 18 556 235 220 209 197 34 1.0k
Timothy Bushnell United States 17 660 1.2× 205 0.9× 236 1.1× 229 1.1× 245 1.2× 28 1.2k
Susan Swift United States 14 428 0.8× 482 2.1× 281 1.3× 243 1.2× 115 0.6× 20 1.1k
Stuart A. Berger Canada 23 632 1.1× 126 0.5× 340 1.5× 162 0.8× 83 0.4× 42 1.1k
Keiichi I. Nakayama Japan 14 745 1.3× 237 1.0× 188 0.9× 336 1.6× 70 0.4× 22 1.2k
Paola Borgatti Italy 20 1.0k 1.9× 144 0.6× 273 1.2× 187 0.9× 118 0.6× 32 1.5k
Peta A. Tilbrook Australia 21 737 1.3× 261 1.1× 484 2.2× 402 1.9× 261 1.3× 31 1.5k
L. Taylor United States 13 633 1.1× 108 0.5× 259 1.2× 196 0.9× 144 0.7× 21 1.3k
Muriel D. David France 20 851 1.5× 245 1.0× 397 1.8× 283 1.4× 90 0.5× 26 1.5k
Boris Tchernychev United States 17 365 0.7× 253 1.1× 270 1.2× 172 0.8× 69 0.4× 24 1.0k
Nader Omidvar United Kingdom 13 487 0.9× 190 0.8× 290 1.3× 220 1.1× 72 0.4× 18 946

Countries citing papers authored by S. Peter Klinken

Since Specialization
Citations

This map shows the geographic impact of S. Peter Klinken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Peter Klinken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Peter Klinken more than expected).

Fields of papers citing papers by S. Peter Klinken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Peter Klinken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Peter Klinken. The network helps show where S. Peter Klinken may publish in the future.

Co-authorship network of co-authors of S. Peter Klinken

This figure shows the co-authorship network connecting the top 25 collaborators of S. Peter Klinken. A scholar is included among the top collaborators of S. Peter Klinken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Peter Klinken. S. Peter Klinken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ingley, Evan, Christine J. Payne, David J. McCarthy, et al.. (2006). Csk-binding Protein Mediates Sequential Enzymatic Down-regulation and Degradation of Lyn in Erythropoietin-stimulated Cells. Journal of Biological Chemistry. 281(42). 31920–31929. 38 indexed citations
3.
Ingley, Evan, Christine J. Payne, David J. McCarthy, et al.. (2006). Csk-binding Protein Mediates Sequential Enzymatic Down-regulation and Degradation of Lyn in Erythropoietin-stimulated Cells. Journal of Biological Chemistry. 281(42). 31920–31929. 17 indexed citations
4.
Ingley, Evan, Peta A. Tilbrook, Martin Thompson, et al.. (2004). HLS5, a Novel RBCC (Ring Finger, B Box, Coiled-coil) Family Member Isolated from a Hemopoietic Lineage Switch, Is a Candidate Tumor Suppressor. Journal of Biological Chemistry. 279(9). 8181–8189. 24 indexed citations
5.
Ingley, Evan, Peta A. Tilbrook, & S. Peter Klinken. (2004). New Insights into the Regulation of Erythroid Cells. IUBMB Life. 56(4). 177–184. 41 indexed citations
6.
Winteringham, Louise N, Simon Kobelke, James H. Williams, Evan Ingley, & S. Peter Klinken. (2004). Myeloid Leukemia Factor 1 inhibits erythropoietin-induced differentiation, cell cycle exit and p27Kip1 accumulation. Oncogene. 23(29). 5105–5109. 41 indexed citations
7.
Sarna, Mohinder, Evan Ingley, Samantha J. Busfield, et al.. (2003). Differential regulation of SOCS genes in normal and transformed erythroid cells. Oncogene. 22(21). 3221–3230. 26 indexed citations
8.
Klinken, S. Peter. (2002). Red blood cells. The International Journal of Biochemistry & Cell Biology. 34(12). 1513–1518. 116 indexed citations
9.
Greene, Wayne K., Jette Ford, Peta A. Tilbrook, et al.. (2002). Enforced expression of HOX11 is associated with an immature phenotype in J2E erythroid cells. British Journal of Haematology. 118(3). 909–917. 13 indexed citations
10.
Tilbrook, Peta A., Shane M. Colley, David McCarthy, Richard Marais, & S. Peter Klinken. (2001). Erythropoietin-Stimulated Raf-1 Tyrosine Phosphorylation Is Associated with the Tyrosine Kinase Lyn in J2E Erythroleukemic Cells. Archives of Biochemistry and Biophysics. 396(1). 128–132. 22 indexed citations
11.
Ingley, Evan, J. H. Williams, C. E. Walker, et al.. (1999). A novel ADP‐ribosylation like factor (ARL‐6), interacts with the protein‐conducting channel SEC61β subunit. FEBS Letters. 459(1). 69–74. 72 indexed citations
12.
Tilbrook, Peta A. & S. Peter Klinken. (1999). The erythropoietin receptor. The International Journal of Biochemistry & Cell Biology. 31(10). 1001–1005. 37 indexed citations
13.
Colley, Shane M., Peta A. Tilbrook, & S. Peter Klinken. (1997). Increased transcription of the Eμ-myc transgene and mRNA stabilisation produce only a modest elevation in Myc protein. Oncogene. 14(22). 2735–2739. 4 indexed citations
14.
Chappell, David, et al.. (1997). Prevention of apoptosis in J2E erythroid cells by erythropoietin: involvement of JAK2 but not MAP kinases. Cell Death and Differentiation. 4(2). 105–113. 20 indexed citations
15.
Busfield, Samantha J., et al.. (1997). Complex Regulation of Transferrin Receptors during Erythropoietin‐Induced Differentiation of J2E Erythroid Cells. European Journal of Biochemistry. 249(1). 77–84. 27 indexed citations
16.
Beilharz, Manfred W., et al.. (1995). Interferon-α Inhibits Erythropoietin-Induced Proliferation, but Not Differentiation, and Restricts Erythroleukemia Development. Journal of Interferon & Cytokine Research. 15(8). 669–675. 6 indexed citations
17.
Busfield, Samantha J., et al.. (1993). Clonal Analysis of Erythropoietin Stimulated J2E Cells Reveals Asynchrony During Terminal Differentiation. Growth Factors. 9(4). 307–315. 16 indexed citations
18.
Beilharz, Manfred W., et al.. (1992). Biological activities of recombinant murine interferons alpha 1 and alpha 4: large difference in antiproliferative effect. Antiviral Research. 19(2). 149–159. 19 indexed citations
19.
Klinken, S. Peter. (1989). ONCOGENES: PAST, PRESENT AND FUTURE. Clinical and Experimental Pharmacology and Physiology. 16(6). 505–509. 1 indexed citations
20.
Klinken, S. Peter & Patricia M. Stevenson. (1984). Cyclic AMP and steroidogenesis in superovulated rat ovaries. International Journal of Biochemistry. 16(7). 823–827.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026